Brain Electrophysiology and Epilepsy Lab, Epilepsy Unit, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Laboratory of Early Markers of Neurodegeneration, Center for the Study of Movement, Cognition and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Brain Behav. 2023 Feb;13(2):e2872. doi: 10.1002/brb3.2872. Epub 2023 Jan 5.
Juvenile myoclonic epilepsy (JME) is characterized by generalized seizures. Nearly 30% of JME patients are drug-resistant (DR-JME), indicating a widespread cortical dysfunction. Walking is an important function that necessitates orchestrated coordination of frontocentral cortical regions. However, gait alterations in JME have been scarcely investigated. Our aim was to assess changes in gait and motor-evoked responses in DR-JME patients.
Twenty-nine subjects (11 JME drug-responder, 8 DR-JME, and 10 healthy controls) underwent a gait analyses during usual walking and dual-task walking. Later, subjects underwent 64-channel EEG recordings while performing a simple motor task. We calculated the motor-evoked current source densities (CSD) at a priori chosen cortical regions. Gait and CSD measures were compared between groups and tasks using mixed model analysis.
DR-JME patients demonstrated an altered gait pattern that included slower gait speed (p = .018), reduced cadence (p = .003), and smaller arm-swing amplitude (p = .011). The DR-JME group showed higher motor-evoked CSD in the postcentral gyri compared to responders (p = .049) and both JME groups showed higher CSD in the superior frontal gyri compared to healthy controls (p < .011). Moreover, higher CSD in the superior frontal gyri correlated with worse performance in dual-task walking (r > |-0.494|, p < .008).
These alterations in gait and motor-evoked responses in DRE-JME patients reflect a more severe dysfunction of motor-cognitive neural processing in frontocentral regions, leading to poorer gait performance. Further studies are needed to investigate the predictive value of altered gait and cortical motor processing as biomarkers for poor response to treatment in JME and other epilepsy syndromes.
青少年肌阵挛癫痫(JME)的特征是全身性发作。近 30%的 JME 患者对药物耐药(DR-JME),表明广泛的皮质功能障碍。行走是一种重要的功能,需要协调额叶皮质区域的运动。然而,JME 的步态改变很少被研究。我们的目的是评估 DR-JME 患者的步态和运动诱发电位的变化。
29 名受试者(11 名 JME 药物反应者、8 名 DR-JME 患者和 10 名健康对照者)在常规行走和双重任务行走期间进行步态分析。之后,受试者在执行简单运动任务时进行 64 通道 EEG 记录。我们在预先选择的皮质区域计算运动诱发电流源密度(CSD)。使用混合模型分析比较组间和任务间的步态和 CSD 测量值。
DR-JME 患者的步态模式发生改变,表现为步行速度较慢(p=0.018)、步频降低(p=0.003)和手臂摆动幅度减小(p=0.011)。与反应者相比,DR-JME 组后中央回的运动诱发电位 CSD 更高(p=0.049),与健康对照组相比,JME 两组的额上回的 CSD 更高(p<0.011)。此外,额上回的 CSD 与双重任务行走时的表现更差呈正相关(r>|-0.494|,p<0.008)。
DR-JME 患者的这些步态和运动诱发电位改变反映了额叶中央区域运动认知神经处理的更严重功能障碍,导致步态表现更差。需要进一步研究以探讨改变的步态和皮质运动处理作为 JME 和其他癫痫综合征治疗反应不良的预测生物标志物的预测价值。